Cargando…
Risk factors of late lesion growth after acute ischemic stroke treatment
BACKGROUND: Even days after treatment of acute ischemic stroke due to a large vessel occlusion, the infarct lesion continues to grow. This late, subacute growth is associated with unfavorable functional outcome. In this study, we aim to identify patient characteristics that are risk factors of late,...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9581245/ https://www.ncbi.nlm.nih.gov/pubmed/36277932 http://dx.doi.org/10.3389/fneur.2022.977608 |
_version_ | 1784812577840168960 |
---|---|
author | Konduri, Praneeta Bucker, Amber Boers, Anna Dutra, Bruna Samuels, Noor Treurniet, Kilian Berkhemer, Olvert Yoo, Albert van Zwam, Wim van Oostenbrugge, Robert van der Lugt, Aad Dippel, Diederik Roos, Yvo Bot, Joost Majoie, Charles Marquering, Henk |
author_facet | Konduri, Praneeta Bucker, Amber Boers, Anna Dutra, Bruna Samuels, Noor Treurniet, Kilian Berkhemer, Olvert Yoo, Albert van Zwam, Wim van Oostenbrugge, Robert van der Lugt, Aad Dippel, Diederik Roos, Yvo Bot, Joost Majoie, Charles Marquering, Henk |
author_sort | Konduri, Praneeta |
collection | PubMed |
description | BACKGROUND: Even days after treatment of acute ischemic stroke due to a large vessel occlusion, the infarct lesion continues to grow. This late, subacute growth is associated with unfavorable functional outcome. In this study, we aim to identify patient characteristics that are risk factors of late, subacute lesion growth. METHODS: Patients from the MR CLEAN trial cohort with good quality 24 h and 1-week follow up non-contrast CT scans were included. Late Lesion growth was defined as the difference between the ischemic lesion volume assessed after 1-week and 24-h. To identify risk factors, patient characteristics associated with lesion growth (categorized in quartiles) in univariable ordinal analysis (p < 0.1) were included in a multivariable ordinal regression model. RESULTS: In the 226 patients that were included, the median lesion growth was 22 (IQR 10–45) ml. In the multivariable model, lower collateral capacity [aOR: 0.62 (95% CI: 0.44–0.87); p = 0.01], longer time to treatment [aOR: 1.04 (1–1.08); p = 0.04], unsuccessful recanalization [aOR: 0.57 (95% CI: 0.34–0.97); p = 0.04], and larger midline shift [aOR: 1.18 (95% CI: 1.02–1.36); p = 0.02] were associated with late lesion growth. CONCLUSION: Late, subacute, lesion growth occurring between 1 day and 1 week after ischemic stroke treatment is influenced by lower collateral capacity, longer time to treatment, unsuccessful recanalization, and larger midline shift. Notably, these risk factors are similar to the risk factors of acute lesion growth, suggesting that understanding and minimizing the effects of the predictors for late lesion growth could be beneficial to mitigate the effects of ischemia. |
format | Online Article Text |
id | pubmed-9581245 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-95812452022-10-20 Risk factors of late lesion growth after acute ischemic stroke treatment Konduri, Praneeta Bucker, Amber Boers, Anna Dutra, Bruna Samuels, Noor Treurniet, Kilian Berkhemer, Olvert Yoo, Albert van Zwam, Wim van Oostenbrugge, Robert van der Lugt, Aad Dippel, Diederik Roos, Yvo Bot, Joost Majoie, Charles Marquering, Henk Front Neurol Neurology BACKGROUND: Even days after treatment of acute ischemic stroke due to a large vessel occlusion, the infarct lesion continues to grow. This late, subacute growth is associated with unfavorable functional outcome. In this study, we aim to identify patient characteristics that are risk factors of late, subacute lesion growth. METHODS: Patients from the MR CLEAN trial cohort with good quality 24 h and 1-week follow up non-contrast CT scans were included. Late Lesion growth was defined as the difference between the ischemic lesion volume assessed after 1-week and 24-h. To identify risk factors, patient characteristics associated with lesion growth (categorized in quartiles) in univariable ordinal analysis (p < 0.1) were included in a multivariable ordinal regression model. RESULTS: In the 226 patients that were included, the median lesion growth was 22 (IQR 10–45) ml. In the multivariable model, lower collateral capacity [aOR: 0.62 (95% CI: 0.44–0.87); p = 0.01], longer time to treatment [aOR: 1.04 (1–1.08); p = 0.04], unsuccessful recanalization [aOR: 0.57 (95% CI: 0.34–0.97); p = 0.04], and larger midline shift [aOR: 1.18 (95% CI: 1.02–1.36); p = 0.02] were associated with late lesion growth. CONCLUSION: Late, subacute, lesion growth occurring between 1 day and 1 week after ischemic stroke treatment is influenced by lower collateral capacity, longer time to treatment, unsuccessful recanalization, and larger midline shift. Notably, these risk factors are similar to the risk factors of acute lesion growth, suggesting that understanding and minimizing the effects of the predictors for late lesion growth could be beneficial to mitigate the effects of ischemia. Frontiers Media S.A. 2022-10-05 /pmc/articles/PMC9581245/ /pubmed/36277932 http://dx.doi.org/10.3389/fneur.2022.977608 Text en Copyright © 2022 Konduri, Bucker, Boers, Dutra, Samuels, Treurniet, Berkhemer, Yoo, van Zwam, van Oostenbrugge, van der Lugt, Dippel, Roos, Bot, Majoie, Marquering and the MR CLEAN Trial Investigators (Multicenter Randomized Clinical Trial of Endovascular Treatment for Acute Ischemic Stroke in the Netherlands). https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Neurology Konduri, Praneeta Bucker, Amber Boers, Anna Dutra, Bruna Samuels, Noor Treurniet, Kilian Berkhemer, Olvert Yoo, Albert van Zwam, Wim van Oostenbrugge, Robert van der Lugt, Aad Dippel, Diederik Roos, Yvo Bot, Joost Majoie, Charles Marquering, Henk Risk factors of late lesion growth after acute ischemic stroke treatment |
title | Risk factors of late lesion growth after acute ischemic stroke treatment |
title_full | Risk factors of late lesion growth after acute ischemic stroke treatment |
title_fullStr | Risk factors of late lesion growth after acute ischemic stroke treatment |
title_full_unstemmed | Risk factors of late lesion growth after acute ischemic stroke treatment |
title_short | Risk factors of late lesion growth after acute ischemic stroke treatment |
title_sort | risk factors of late lesion growth after acute ischemic stroke treatment |
topic | Neurology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9581245/ https://www.ncbi.nlm.nih.gov/pubmed/36277932 http://dx.doi.org/10.3389/fneur.2022.977608 |
work_keys_str_mv | AT konduripraneeta riskfactorsoflatelesiongrowthafteracuteischemicstroketreatment AT buckeramber riskfactorsoflatelesiongrowthafteracuteischemicstroketreatment AT boersanna riskfactorsoflatelesiongrowthafteracuteischemicstroketreatment AT dutrabruna riskfactorsoflatelesiongrowthafteracuteischemicstroketreatment AT samuelsnoor riskfactorsoflatelesiongrowthafteracuteischemicstroketreatment AT treurnietkilian riskfactorsoflatelesiongrowthafteracuteischemicstroketreatment AT berkhemerolvert riskfactorsoflatelesiongrowthafteracuteischemicstroketreatment AT yooalbert riskfactorsoflatelesiongrowthafteracuteischemicstroketreatment AT vanzwamwim riskfactorsoflatelesiongrowthafteracuteischemicstroketreatment AT vanoostenbruggerobert riskfactorsoflatelesiongrowthafteracuteischemicstroketreatment AT vanderlugtaad riskfactorsoflatelesiongrowthafteracuteischemicstroketreatment AT dippeldiederik riskfactorsoflatelesiongrowthafteracuteischemicstroketreatment AT roosyvo riskfactorsoflatelesiongrowthafteracuteischemicstroketreatment AT botjoost riskfactorsoflatelesiongrowthafteracuteischemicstroketreatment AT majoiecharles riskfactorsoflatelesiongrowthafteracuteischemicstroketreatment AT marqueringhenk riskfactorsoflatelesiongrowthafteracuteischemicstroketreatment AT riskfactorsoflatelesiongrowthafteracuteischemicstroketreatment |